Despite significant progress in prevention and therapy of ischemic heart disease, treating patients with heart failure after myocardial infarction remains a major thera-peutic challenge. Adult cardiomyocytes cannot regenerat
Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic hear...
Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic hear...
Ischemic heart disease is the leading cause of mortality worldwide. Its most frequent and serious co...
Heart failure is a serious and very common clinical condition in which the heart is about to stop wo...
Gene therapy, aimed at the correction of key pathologies being out of reach for conventional drugs, ...
AbstractRegenerating the human heart is a challenge that has engaged researchers and clinicians arou...
Despite considerable improvements in the treatment of cardiovascular diseases, heart failure (HF) st...
Cardiac repair is a dream in the field of medical science. The biological limitations to human cardi...
Heart failure affects more than 30 million people worldwide. Therapies for both congenital and acqui...
Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic ...
Abstract—With increasing knowledge of basic molecular mechanisms governing the development of heart ...
Cell-based interventions, angiogenesis and gene therapy are among the newest treatment modalities th...
Cell therapy is emerging as a new strategy to circumvent the adverse effects of heart disease. Many ...
Heart regeneration via stem cell therapy could improve the functional outcome for millions of patien...
Contrary to the initial belief that the heart is a terminally differentiated organ that cannot repla...
Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic hear...
Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic hear...
Ischemic heart disease is the leading cause of mortality worldwide. Its most frequent and serious co...
Heart failure is a serious and very common clinical condition in which the heart is about to stop wo...
Gene therapy, aimed at the correction of key pathologies being out of reach for conventional drugs, ...
AbstractRegenerating the human heart is a challenge that has engaged researchers and clinicians arou...
Despite considerable improvements in the treatment of cardiovascular diseases, heart failure (HF) st...
Cardiac repair is a dream in the field of medical science. The biological limitations to human cardi...
Heart failure affects more than 30 million people worldwide. Therapies for both congenital and acqui...
Ischemic myocardial disease, the main cause of heart failure, is a major public health and economic ...
Abstract—With increasing knowledge of basic molecular mechanisms governing the development of heart ...
Cell-based interventions, angiogenesis and gene therapy are among the newest treatment modalities th...
Cell therapy is emerging as a new strategy to circumvent the adverse effects of heart disease. Many ...
Heart regeneration via stem cell therapy could improve the functional outcome for millions of patien...
Contrary to the initial belief that the heart is a terminally differentiated organ that cannot repla...
Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic hear...
Despite improvements in modern cardiovascular therapy, the morbidity and mortality of ischaemic hear...
Ischemic heart disease is the leading cause of mortality worldwide. Its most frequent and serious co...
Add to ORKG